5-Aminolevulinic acid, commonly known as 5-ALA, is an amino acid derivative naturally synthesized in the human body that carries enormous significance both biochemically and clinically. Serving as the initiating substrate of heme biosynthesis — the fundamental component of cellular energy production — 5-ALA has emerged in medicine as a revolutionary tool, particularly in brain tumor surgery and in the photodiagnostic and photodynamic treatment of various cancer types.

Biochemical Structure and Natural Role

5-ALA is formed within the mitochondria through the condensation of glycine and succinyl-CoA. The enzyme that catalyzes this reaction is ALA synthase, and this step represents the rate-limiting stage of heme biosynthesis. The resulting 5-ALA is transported into the cytosol, where it undergoes a series of enzymatic transformations — first into porphobilinogen, then into uroporphyrinogen, coproporphyrinogen, and ultimately into protoporphyrin IX (PpIX). The addition of iron to protoporphyrin IX yields heme, which is the structural component of hemoglobin, myoglobin, and cytochrome enzymes.

The Mechanism of Accumulation in Tumor Tissue

The most clinically critical property of 5-ALA is its selective accumulation in tumor cells when administered exogenously at high doses. Exogenously administered 5-ALA is metabolized harmlessly in normal cells, where it is efficiently converted to heme. In tumor cells, however, this conversion is incomplete, and protoporphyrin IX accumulates intracellularly as an intermediate product. The primary reason for this is the reduced activity of ferrochelatase in tumor cells — the enzyme responsible for the final step that incorporates iron into PpIX to complete heme synthesis.

Protoporphyrin IX is a potent fluorescent compound. When excited by blue light at approximately 405–410 nm wavelength, it emits a bright red-pink fluorescence. This property makes it possible to visually distinguish tumor tissue from the surrounding healthy tissue.

Its Role in Brain Tumor Surgery

The most widely used and best-documented clinical application of 5-ALA is in the surgery of high-grade gliomas. In high-grade gliomas, most notably glioblastoma, maximal safe resection is a decisive factor for both the preservation of neurological function and overall survival.

5-ALA is administered orally to the patient three to four hours before surgery. During the procedure, a specialized microscope equipped with a blue-violet fluorescence filter is used in place of standard white light. Tumor tissue appears in a bright red-pink color, while healthy brain tissue produces no fluorescence under this light. The surgeon can thus visualize tumor margins in real time and guide the resection accordingly.

Clinical trials have demonstrated that 5-ALA-guided resection significantly increases the rate of complete resection and six-month progression-free survival compared to resection performed under standard white light. On the basis of these data, 5-ALA was approved in Europe in 2007 and in the United States in 2017.

Photodynamic Therapy

Another important application of 5-ALA is photodynamic therapy (PDT). In this therapeutic approach, following 5-ALA administration, light of an appropriate wavelength is delivered to the tumor site. PpIX activated by light generates reactive oxygen species in the presence of oxygen, and these compounds exert a selective cytotoxic effect on tumor cells.

5-ALA-based photodynamic therapy is used particularly in the following conditions: actinic keratosis, superficial basal cell carcinoma, Bowen’s disease, and certain bladder tumors. Topical 5-ALA formulations have gained wide acceptance in the treatment of cutaneous lesions.

Its Use in the Diagnosis of Bladder Cancer

5-ALA cystoscopy has established an important role in the diagnosis and follow-up of superficial bladder cancer. Fluorescence cystoscopy performed after intravesical instillation of 5-ALA provides superior sensitivity compared to standard white-light cystoscopy, particularly in the detection of carcinoma in situ and small papillary tumors. This approach increases the detection rate of lesions that may be missed during routine cystoscopy.

Safety Profile and Side Effects

Since 5-ALA is a compound naturally synthesized in the body, it is generally well tolerated. Nevertheless, certain side effects have been reported. The most important safety concern is transient phototoxicity; patients must avoid sunlight and bright artificial light for 24 to 48 hours following drug administration. Nausea and hypotension are among the other reported side effects. Transient elevations in liver enzymes may be observed, and caution is therefore warranted in patients with hepatic insufficiency. It must not be used in patients with porphyria under any circumstances.

Current Developments and Future Directions

Research into 5-ALA is actively ongoing. The extension of fluorescence-guided surgery to other brain tumor types — including low-grade gliomas, meningiomas, and metastases — is under investigation. Its combination with robotic surgery and artificial intelligence-assisted image analysis holds the potential to further refine the interpretation of fluorescence signals. In addition, the use of 5-ALA derivatives in systemic photodynamic therapy for other cancer types continues to occupy a prominent place on the research agenda.

Conclusion

5-Aminolevulinic acid is a unique compound that transforms a molecule arising from the body’s own metabolic processes into a clinical tool. The contributions it makes to surgical visualization and photodynamic therapy through its selective accumulation in tumor cells and the fluorescence it generates are particularly meaningful in tumors such as glioblastoma, where prognosis remains poor. The impact that this simple amino acid derivative has made on oncology stands as one of the most striking examples of how medicinal chemistry can transform clinical practice.